JPH06104122B2 - β▲下２▼−ミクログロブリン除去カラム - Google Patents

β▲下２▼−ミクログロブリン除去カラム

Info

Publication number
JPH06104122B2
JPH06104122B2 JP61-504911A JP50491186A JPH06104122B2 JP H06104122 B2 JPH06104122 B2 JP H06104122B2 JP 50491186 A JP50491186 A JP 50491186A JP H06104122 B2 JPH06104122 B2 JP H06104122B2
Authority
JP
Japan
Prior art keywords
microglobulin
column
antibody
blood
removal column
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61-504911A
Other languages
English (en)
Japanese (ja)
Other versions
JPH06104122B1 (de
JPWO1987001597A1 (ja
Inventor
信夫 井田
浩 片岡
哲之輔 国友
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP61-504911A priority Critical patent/JPH06104122B2/ja
Publication of JPWO1987001597A1 publication Critical patent/JPWO1987001597A1/ja
Publication of JPH06104122B1 publication Critical patent/JPH06104122B1/ja
Publication of JPH06104122B2 publication Critical patent/JPH06104122B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0415—Plasma
    • A61M2202/0421—Beta-2-microglobulin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • External Artificial Organs (AREA)
JP61-504911A 1985-09-19 1986-09-18 β▲下２▼−ミクログロブリン除去カラム Expired - Lifetime JPH06104122B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61-504911A JPH06104122B2 (ja) 1985-09-19 1986-09-18 β▲下２▼−ミクログロブリン除去カラム

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP60-207250 1985-09-19
JP20725085 1985-09-19
JP61-504911A JPH06104122B2 (ja) 1985-09-19 1986-09-18 β▲下２▼−ミクログロブリン除去カラム
PCT/JP1986/000485 WO1987001597A1 (en) 1985-09-19 1986-09-18 beta2-MICROGLOBULIN-REMOVING COLUMN

Publications (3)

Publication Number Publication Date
JPWO1987001597A1 JPWO1987001597A1 (ja) 1987-09-03
JPH06104122B1 JPH06104122B1 (de) 1994-12-21
JPH06104122B2 true JPH06104122B2 (ja) 1994-12-21

Family

ID=16536693

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61-504911A Expired - Lifetime JPH06104122B2 (ja) 1985-09-19 1986-09-18 β▲下２▼−ミクログロブリン除去カラム

Country Status (5)

Country Link
US (1) US4770774A (de)
EP (1) EP0236509B1 (de)
JP (1) JPH06104122B2 (de)
DE (1) DE3687751T2 (de)
WO (1) WO1987001597A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9409146B2 (en) 2002-12-19 2016-08-09 New York University Method for treating amyloid disease

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073265A (en) * 1987-02-27 1991-12-17 Johnson Richard J Methods of manufacturing nucleophilic material modified for improved biocompatibility
EP0319144A1 (de) * 1987-11-06 1989-06-07 Asahi Kasei Kogyo Kabushiki Kaisha Sorbentmittel für beta-2-Mikroglobulin
ES2048191T3 (es) * 1987-12-11 1994-03-16 Akzo Nv Membrana de dialisis biocompatible a base de celulosa con adsorcion incrementada de beta-2-microglobulina.
US5092992A (en) * 1989-06-07 1992-03-03 J. T. Baker Inc. Polyethyleneimine matrixes for affinity chromatography
US5085779A (en) * 1989-06-07 1992-02-04 J. T. Baker, Inc. Polyethyleneimine matrixes for affinity chromatography
US20020164818A1 (en) * 1995-05-23 2002-11-07 Gruber Karl F. Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
EP0819439B1 (de) * 1996-01-31 2005-11-30 Kaneka Corporation Vorrichtung mit adsorbens zum adsorptiven entfernen von krankheitsbedingten faktoren in körperflüssigkeiten
US6878269B2 (en) * 1996-01-31 2005-04-12 Kaneka Corporation Device for body fluid purification and system for body fluid purification
FR2785200B1 (fr) * 1998-10-30 2001-03-30 Centre Nat Rech Scient Utilisation d'un gel adsorbant pour eliminer et purifier les biomolecules
EP1066843B1 (de) * 1998-12-24 2011-08-24 Toray Industries, Inc. Säule zur blutreinigung
UA81216C2 (en) * 1999-06-01 2007-12-25 Prevention and treatment of amyloid disease
EP1315551B1 (de) * 1999-06-03 2015-11-04 Advanced Extravascular Systems Entfernung von unerwünschten molekülen aus zirkulierendem blut in einem schritt
US8865172B2 (en) 2000-05-08 2014-10-21 Advanced Extravascular Systems, Inc. Method for reducing the number of unwanted molecules in bodily fluids
BR0316232A (pt) * 2002-11-12 2005-10-04 Becton Dickinson Co Métodos para determinar o estado de sepsia, para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo
AT413336B (de) * 2003-09-12 2006-02-15 Mattner Frank Dr Apherese-vorrichtung
WO2005063335A2 (en) * 2003-12-30 2005-07-14 Statens Serum Institut MONOCLONAL DES-LYS58-β2-MICROGLOBULIN ANTIBODIES FOR MEASUREMENT AND MANAGEMENT OF HEMODIALYSIS COMPLICATIONS
JP2008538007A (ja) 2005-04-15 2008-10-02 ベクトン，ディッキンソン アンド カンパニー 敗血症の診断
AT502691A1 (de) * 2005-10-24 2007-05-15 Univ Fuer Weiterbildung Krems Extrakorporales blut- oder plasmareinigungssystem
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
EP2488228A4 (de) * 2009-10-18 2018-03-21 Glycorex AB Verfahren und produkte zur blutbehandlung und -reinigung
US20160208011A1 (en) 2010-01-28 2016-07-21 The Board Of Trustees Of The Leland Stanford Junior University Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same
JP7134089B2 (ja) * 2015-05-18 2022-09-09 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 老化に関連した障害を処置するための方法及び組成物
AU2016279804B2 (en) 2015-06-15 2019-03-07 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating aging-associated conditions
EP3192806A1 (de) 2016-01-13 2017-07-19 Affiris AG Alpha-kette des hochaffinen ige-rezeptors (fceria)
JP6910033B2 (ja) 2016-08-01 2021-07-28 株式会社カネカ カルシプロテインパーティクルの吸着材、および吸着除去システムとその利用方法
DE102017210134A1 (de) 2016-12-15 2018-06-21 Fresenius Medical Care Deutschland Gmbh System zur extrakorporalen Blutbehandlung, Behandlungsvorrichtung, Kit und Verfahren zum Betreiben eines Systems zur extrakorporalen Blutbehandlung
WO2019084111A1 (en) * 2017-10-24 2019-05-02 DD Innovations Lab, LLC APPARATUS AND METHODS FOR REMOVING TOXINS FROM BLOOD BY PLASMASPHERESIS
DE102017131192A1 (de) 2017-12-22 2019-06-27 Fresenius Medical Care Deutschland Gmbh Pufferlösung zur Reduzierung des Kohlendioxidgehaltes in extrakorporalem Blut

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3669878A (en) * 1968-12-02 1972-06-13 Health Education And Welfare U Treatment of dialysate solution for removal of urea
JPS5437821A (en) * 1977-08-29 1979-03-20 Seikagaku Kogyo Co Ltd Blood cells sensitized to antibody against anti-beta2-microglobulin of man, their preparation and determination of beta2-microglobulin of man
JPS5530652A (en) * 1978-08-28 1980-03-04 Seikagaku Kogyo Co Ltd Latex sensitive to antibody of human beta2-microglobulin for quantitizing human beta2-microglobulin and its composite
US4257884A (en) * 1979-04-17 1981-03-24 Damon Corporation Chromatography
JPS5693046A (en) * 1979-11-20 1981-07-28 Fujirebio Inc Determination of beta2-microglobulin by enzime immunity measuring method
US4321192A (en) * 1980-01-10 1982-03-23 Ionics Incorporated Fractionation of protein mixtures by salt addition followed by dialysis treatment
US4329152A (en) * 1980-10-06 1982-05-11 International Lead Zinc Research Organization, Inc. Determination of β2 -microglobulin in human urine and serum by latex immunoassay
DE3206729A1 (de) * 1982-02-25 1983-09-01 Behringwerke Ag, 3550 Marburg Immunologisches agglutinationsverfahren

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9409146B2 (en) 2002-12-19 2016-08-09 New York University Method for treating amyloid disease

Also Published As

Publication number Publication date
JPH06104122B1 (de) 1994-12-21
EP0236509A4 (de) 1989-05-30
EP0236509A1 (de) 1987-09-16
EP0236509B1 (de) 1993-02-10
DE3687751D1 (de) 1993-03-25
DE3687751T2 (de) 1993-05-27
WO1987001597A1 (en) 1987-04-26
US4770774A (en) 1988-09-13

Similar Documents

Publication Publication Date Title
JPH06104122B2 (ja) β▲下２▼−ミクログロブリン除去カラム
JPWO1987001597A1 (ja) β↓２−ミクログロブリン除去カラム
US4361509A (en) Ultrapurification of factor VIII using monoclonal antibodies
US5122112A (en) Antigen-specific removal of circulating immune complexes
EP0411017B1 (de) Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen
JPS645010B2 (de)
JP3930564B2 (ja) 体外搬出法のための患者特異性免疫吸着剤およびその製出法
JP2002504831A (ja) 自己抗体の除去による心筋症の処置
US5593897A (en) Binding of immune complexes by modified forms of C-reactive protein
CN113226353A (zh) 治疗与抗中性粒细胞胞质抗体相关的疾病的体外装置和方法
EP0272792B1 (de) Antigen-spezifisches Entfernen von zirkulierenden Immunokomplexen
US4762787A (en) Anti-human IGM immunoadsorbent and process for producing said immunoadsorbent
Regnault et al. Specific removal of transthyretin from plasma of patients with familial amyloidotic polyneuropathy: Optimization of an immunoadsorption procedure
US20100098698A1 (en) Targeted apheresis for the treatment of rheumatoid arthritis
US4863869A (en) Anti-human IGM immunoadsorbent and process for producing said immunoadsorbent
Blomberg et al. Improved removal of anti-A and anti-B antibodies from plasma using blood-group-active haptens
Yamamoto et al. Selective Removal of Anti‐Acetylcholine Receptor Antibodies and IgG In Vitro with an Immunoadsorbent Containing Immobilized Sulfathiazole
Burgstaler et al. Immunoabsorption in an extracorporeal plasma perfusion system: in vitro studies
JP3073501B2 (ja) Ｃ―反応性タンパクの修飾形態による免疫複合体の結合
JPH0120903B2 (de)
Riedstra et al. Study of an anti-human transthyretin immunoadsorbent: influence of coupling chemistry on binding capacity and ligand leakage
Pak et al. Extraction of circulating gastrointestinal cancer antigen using solid-phase immunoadsorption system of monoclonal antibody-coupled membrane
RU2325172C2 (ru) Сорбент для удаления иммуноглобулинов
Müller-Schulte et al. Removal of β2-microglobulin using grafted affinity adsorbents as therapeutic approach for the treatment of hemodialysis patients
Neitz et al. Purification of Cowdria ruminantium by immunoadsorbent affinity chromatography